Malignant neoplasm of thyroid gland Clinical Trials

23 clinical trials for Malignant neoplasm of thyroid gland across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• HoT – A phase III randomised trial to compare the rates of cancer returning in patients with low-risk differentiated thyroid cancer after a hemithyroidectomy and total thyroidectomy — RECRUITING
• Evaluation of training offers within the framework of the Center for Competence Development in Cancer Self-Help (ZfK KSH) — RECRUITING
• Cross-institutional, prospective, open label, single group basket study of combined CRAF and MEK inhibition in advanced-stage malignancies harboring BRAF mutations with impaired kinase activity — RECRUITING
• Histopathological, molecular and clinical characterization of thyroid cancers. — RECRUITING
• EUROPEAN SURGICAL REGISTRY FOR RARE ENDOCRINE TUMOURS — RECRUITING
• Malignant endocrine tumors in childhood and adolescence — RECRUITING
• Circulating tumor DNA as a noninvasive biomarker in patients with thyroid cancer — RECRUITING
• Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Head and Neck Diseases — RECRUITING
• Prognostic and discriminative power of various lymph node classification systems for patients with cancer of the gastrointestinal tract and the endocrine glands — RECRUITING
• Isolation of primary cells from differentiated thyroid carcinomas to build 2D/3D cell cultures and human tissue — RECRUITING
• Validation of the german transplation of the disease-specific health-related Quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors. — RECRUITING
• Molecular Pathology of Benign and Malignant Thyroid Tumors — RECRUITING
• Continuuous intraoperative neuromonitoring during neck surgery - a prospective, randomized trial — RECRUITING
• Can Selumetinib make advanced thyroid cancer sensitive to radioactive iodine therapy again? — TERMINATED
• Patient-derived organoids in advanced thyroid carcinoma as a platform for precision oncology — NOT_YET_RECRUITING
• Phase II, Open-label, Study in Patients with anaplastic (ATC) or poorly differentiated thyroid carcinomas (PDTC) to investigate the Clinical Efficacy and Safety of the Combination Therapy of Lenvatinib and Pembrolizumab — OTHER
• Multicenter retrospective evaluation of predictive and prognostic factors in radiochemo-/radiotherapy of anaplastic thyroid cancer — OTHER
• Survey on return to work, quality of life and long-term survival in patients with thyroid cancer Long-term survival in patients with thyroid carcinoma (ALSi) - a multicenter prospective study. — NOT_YET_RECRUITING
• Retrospective Determination of BRAF V600E Mutation in Papillary Thyroid Cancer — OTHER
• Trial on Intraoperative Neuromonitoring (IONM) in Thyroid Cancer Surgery. — OTHER · NA
• Everyday-based general and visceral surgical case volume, outcome and quality assurance ("real world data") in the elective and emergency setting of a university clinic in a consecutive patient cohort with regard to the season and the influence of the CoVID-19 pandemic — OTHER
• Open label Phase I Study of Everolimus(RAD001) plus Doxorubicin in advanced progressive and refractory thyroid cancer — OTHER
• Randomized, double-blind, placebo controlled Phase II study to evaluate the efficacy and safety of Sorafenib treatment in patients with advanced (recurrent, persistent and/or metastasizing) medullary thyroid carcinoma (SUMMIT). — OTHER

Refine this search